Cloxacillin

Cloxacillin
Clinical data
Trade names Cloxapen
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Oral, IM
ATC code J01CF02 (WHO) QJ51CF02 (WHO) QS01AA90 (WHO)
Pharmacokinetic data
Bioavailability 37 to 90%
Protein binding 95%
Biological half-life 30 minutes to 1 hour
Excretion Renal and biliary
Identifiers
CAS Number 61-72-3 YesY
PubChem (CID) 6098
DrugBank DB01147 YesY
ChemSpider 5873 YesY
UNII O6X5QGC2VB YesY
KEGG D07733 YesY
ChEBI CHEBI:49566 YesY
ChEMBL CHEMBL891 YesY
ECHA InfoCard 100.000.468
Chemical and physical data
Formula C19H18ClN3O5S
Molar mass 435.88 g/mol
3D model (Jmol) Interactive image
  (verify)

Cloxacillin is an antibiotic useful for the treatment of a number of bacterial infections. It is semisynthetic and in the same class as penicillin.

Cloxacillin is used against staphylococci that produce beta-lactamase, due to its large R chain, which does not allow the beta-lactamases to bind. This drug has a weaker antibacterial activity than benzylpenicillin, and is devoid of serious toxicity except for allergic reactions.

Cloxacillin was discovered and developed by Beecham.[1] It is sold under a number of trade names, including Cloxapen, Cloxacap, Tegopen and Orbenin. It is on the World Health Organization's List of Essential Medicines, the most important medication needed in a basic health system.[2]

See also

References

  1. David Greenwood (2008). Antimicrobial drugs: chronicle of a twentieth century medical triumph. Oxford University Press US. pp. 124–. ISBN 978-0-19-953484-5. Retrieved 18 November 2010.
  2. "WHO Model List of EssentialMedicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.